More good news for Parkinson’s treatment

Israel’s NeuroDerm has released positive preliminary results for the final Phase II trial of its ND0612H treatment on 38 patients with advanced Parkinson’s disease.  NeuroDerm will now proceed with Phase III trials on 240 patients prior to requesting CE (European) Certification.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *